Akèy › Maladi sèvo › Texas › Houston

Etid klinik pou Maladi sèvo nan Houston, TX

6 etid pou Maladi sèvo ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Ap rekriteFaz 2

Houston Methodist Hospital, Houston
The University of Texas Health Science Center at Houston, Houston

Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

Ap rekriteFaz 1/2

University of Texas MD Anderson Cancer Center, Houston

Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT05386108

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

Ap rekriteFaz 1

MD Anderson Cancer Center, Houston

36 Months – 22 Years · Tout sèks · Mizajou Sep 4, 2026 · NCT03911388

Study of Selected X-Linked Disorders: Aicardi Syndrome

Ap rekriteEtid obsèvasyon

Baylor College of Medicine, Houston

Tout laj · Tout sèks · Mizajou May 5, 2026 · NCT00697411

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi

Baylor College of Medicine, Houston

Tout laj · Tout sèks · Mizajou Feb 4, 2026 · NCT01694940

Open-label Extension Study in Participants With Early Alzheimer's Disease

Ap rekriteFaz 2

GSK Investigational Site, Houston

Laj 50 a 85 · Tout sèks · Mizajou Feb 2, 2026 · NCT07105709

Etid Maladi sèvo nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.